Search

everythinglearnresearchcommunity

for

Search:↓

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

A woman with severe angioedema improved significantly after treatment with rituximab.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Upadacitinib effectively treats psoriasis and lichen planus together.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Alefacept does not effectively treat severe alopecia areata.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.